Artificial intelligence in drug development: present status and future prospects

Artificial intelligence in healthcare: past, present and future

Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837

Can the pharmaceutical industry reduce attrition rates?

Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167

Principles of early drug discovery

Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859

Artificial intelligence in medicine

Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334

Diagnosing the decline in pharmaceutical R&D efficiency

Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981

Planning chemical syntheses with deep neural networks and symbolic AI

Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847

The rise of deep learning in drug discovery

Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537

Deep Learning in Medical Imaging: General Overview

Lee, J., Jun, S., Cho, Y.-W., Lee, H., Kim, G. B., Seo, J. B., & Kim, N. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.4.570 · Cited by 1,328

Organs-on-chips at the frontiers of drug discovery

Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185

DeepTox: toxicity prediction using deep learning

Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081

The Drug Repurposing Hub: a next-generation drug library and information resource

Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P. R., Hirschman, J., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,028

Automating drug discovery

Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · cited 1×

Wearable Devices in Medical Internet of Things: Scientific Research and Commercially Available Devices

Haghi, M., Thurow, K., & Stoll, R. (2017) · Healthcare Informatics Research · doi:10.4258/hir.2017.23.1.4 · Cited by 712

Drug discovery and development: Role of basic biological research

Mohs, R. C., & Greig, N. H. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.005 · Cited by 708

Applications of Deep Learning in Biomedicine

Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00982 · Cited by 701

Deep learning improves prediction of drug–drug and drug–food interactions

Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803294115 · Cited by 688

Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data

Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587

How artificial intelligence is changing drug discovery

Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546

Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties

Menden, M. P., Iorio, F., Garnett, M. J., McDermott, U., Benes, C. H., Ballester, P. J., & Sáez-Rodríguez, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061318 · Cited by 543

Google DeepMind and healthcare in an age of algorithms

Powles, J., & Hodson, H. (2017) · Health and Technology · doi:10.1007/s12553-017-0179-1 · Cited by 511

Polypharmacology: drug discovery for the future

Reddy, A. S., & Zhang, S. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.74 · Cited by 498

Sample size calculations: basic principles and common pitfalls

Noordzij, M., Tripepi, G. L., Dekker, F. W., Zoccali, C., Tanck, M. W. T., & Jager, K. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp732 · Cited by 440

Computational approaches in target identification and drug discovery

Κάτσιλα, Θ., Spyroulias, G. A., Patrinos, G. P., & Matsoukas, M. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.04.004 · Cited by 408

De Novo Design of Bioactive Small Molecules by Artificial Intelligence

Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373

Chemical space as a source for new drugs

Reymond, J., van Deursen, R., Blum, L. C., & Ruddigkeit, L. (2010) · MedChemComm · doi:10.1039/c0md00020e · Cited by 359

Ace revisited: A new target for structure-based drug design

Acharya, K. R., Sturrock, E. D., Riordan, J. F., & Ehlers, M. R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1227 · Cited by 341

Machine Learning of Toxicological Big Data Enables Read-Across Structure Activity Relationships (RASAR) Outperforming Animal Test Reproducibility

Luechtefeld, T., Marsh, D., Rowlands, C., & Härtung, T. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy152 · Cited by 328

Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis

Zhu, T., Cao, S., Su, P.-C., Patel, R., Shah, D., Chokshi, H. B., Szukala, R., Johnson, M. E., & Hevener, K. E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301916b · Cited by 321

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy

Labovitz, D. L., Shafner, L., Reyes Gil, M., Virmani, D., & Hanina, A. (2017) · Stroke · doi:10.1161/strokeaha.116.016281 · Cited by 311

A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials

Gayvert, K. M., Madhukar, N. S., & Elemento, O. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.023 · Cited by 310

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

Hernández, J. J., Pryszlak, M., Smith, L., Yanchus, C., Kurji, N., Shahani, V. M., & Molinski, S. V. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00273 · Cited by 281

Emerging trends in geospatial artificial intelligence (geoAI): potential applications for environmental epidemiology

VoPham, T., Hart, J. E., Laden, F., & Chiang, Y. (2018) · Environmental Health · doi:10.1186/s12940-018-0386-x · Cited by 276

Deep into the Brain: Artificial Intelligence in Stroke Imaging

Lee, E., Kim, Y., Kim, N., & Kang, D. (2017) · Journal of Stroke · doi:10.5853/jos.2017.02054 · Cited by 272

How much do clinical trials cost?

Martin, L., Hutchens, M., Hawkins, C., & Radnov, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.70 · Cited by 262

Artificial Intelligence Approaches for Rational Drug Design and Discovery

Duch, W., Swaminathan, K., & Meller, J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780765954 · Cited by 249

Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach

Emig, D., Ivliev, A. E., Pustovalova, O., Lancashire, L., Bureeva, S. V., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 242

An application of machine learning to haematological diagnosis

Gunčar, G., Kukar, M., Notar, M., Brvar, M., Černelč, P., Notar, M., & Notar, M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18564-8 · Cited by 237

A multiple kernel learning algorithm for drug-target interaction prediction

do Nascimento, A. C. A., Prudêncio, R. B. C., & Costa, I. G. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-0890-3 · Cited by 235

Model-based machine learning

Bishop, C. (2013) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2012.0222 · Cited by 218

The rise of artificial intelligence and the uncertain future for physicians

Krittanawong, C. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.06.017 · Cited by 210

LigBuilder 2: A Practical de Novo Drug Design Approach

Yuan, Y., Pei, J., & Lai, L. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100350u · Cited by 207

“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives

Matthews, H., Hanison, J., & Nirmalan, N. J. (2016) · Proteomes · doi:10.3390/proteomes4030028 · Cited by 202

Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis

Bakkar, N., Kovalik, T., Lorenzini, I., Spangler, S., Lacoste, A. M. B., Sponaugle, K., Ferrante, P., Argentinis, E., Sattler, R., & Bowser, R. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1785-8 · Cited by 200

Machine learning and computer vision approaches for phenotypic profiling

Grys, B. T., Lo, D. S., Sahin, N., Kraus, O. Z., Morris, Q., Boone, C. M., & Andrews, B. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201610026 · Cited by 170

Parsing clinical success rates

Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.136 · Cited by 165

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Bain, E., Shafner, L., Walling, D. P., Othman, A. A., Chuang‐Stein, C., Hinkle, J. E., & Hanina, A. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.7030 · Cited by 163

Cross sectional survey of multicentre clinical databases in the United Kingdom

Black, N. A., Barker, M., & Payne, M. (2004) · BMJ · doi:10.1136/bmj.328.7454.1478 · Cited by 141

In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development

Ozerov, I. V., Lezhnina, K. V., Izumchenko, E., Artemov, A. V., Medintsev, S., Vanhaelen, Q., Aliper, A. M., Vijg, J., Osipov, A. N., Labat, I., et al. (2016) · Nature Communications · doi:10.1038/ncomms13427 · Cited by 139

In silico prediction of novel therapeutic targets using gene–disease association data

Ferrero, E., Dunham, I., & Sanséau, P. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1285-6 · Cited by 134

The Cost of Drug Development

DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1504317 · Cited by 118

Strategies to design clinical studies to identify predictive biomarkers in cancer research

Perez‐Gracia, J. L., Sanmamed, M. F., Bosch, A., Patiño‐García, A., Schalper, K. A., Segura, V., Joaquim Bellmunt, B., Tabernero, J. M., Sweeney, C. J., Choueiri, T. K., et al. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.12.005 · Cited by 112

Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor

Rodrigues, T., Werner, M., Roth, J., da Cruz, E. H. G., Marques, M. C., Akkapeddi, P., Lobo, S. A. L., Koeberle, A., Corzana, F., Júnior, E. N. D. S., et al. (2018) · Chemical Science · doi:10.1039/c8sc02634c · Cited by 72

Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma

Young, J. D., Cai, C., & Lu, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1798-2 · Cited by 70

An analysis of the influence of deep neural network (DNN) topology in bottleneck feature based language recognition

Lozano-Díez, A., Zazo, R., Toledano, D. T., & González-Rodríguez, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182580 · Cited by 64

A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data

Swan, A., Stekel, D. J., Hodgman, C. T., Allaway, D., Al-Qahtani, M. H., Mobasheri, A., & Bacardit, J. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s1-s2 · Cited by 61

Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process

Alanine, A. I., Nettekoven, M. H., Roberts, E., & Thomas, A. W. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207033329823 · Cited by 59

Hot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery

Hall, D. R., Ngan, C. H., Zerbe, B. S., Kozakov, D., & Vajda, S. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200468p · Cited by 58

Drug design for ever, from hype to hope

Seddon, G. M., Lounnas, V., McGuire, R., van den Bergh, T., Bywater, R. P., Oliveira, L., & Vriend, G. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9519-9 · Cited by 57

Biotech R&D spend jumps by more than 15%

Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.135 · Cited by 56

Structure-Based Functional Design of Drugs: From Target to Lead Compound

Anderson, A. C. (2011) · Methods in molecular biology · doi:10.1007/978-1-60327-216-2_23 · Cited by 51

A new era of oncology through artificial intelligence

Fontecedro, A. C. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000198 · Cited by 49

ESP: A Method To Predict Toxicity and Pharmacological Properties of Chemicals Using Multiple MCASE Databases

Klopman, G., Chakravarti, S., Zhu, H., Ivanov, J. M., & Saiakhov, R. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci030298n · Cited by 45

A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine

Wang, Q., Feng, Y., Huang, J., Wang, T., & Cheng, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176486 · Cited by 43

Exploring the Potential of Generative Adversarial Networks for Synthesizing Radiological Images of the Spine to be Used in In Silico Trials

Galbusera, F., Niemeyer, F., Seyfried, M., Bassani, T., Casaroli, G., Kienle, A., & Wilke, H. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00053 · Cited by 33

The rise and fall of machine learning methods in biomedical research

Koohy, H. (2018) · F1000Research · doi:10.12688/f1000research.13016.2 · Cited by 31

Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine

Tormay, P. (2015) · Pharmaceutical Medicine · doi:10.1007/s40290-015-0090-x · Cited by 29

Clinical Note Creation, Binning, and Artificial Intelligence

Deliberato, R. O., Celi, L. A., & Stone, D. J. (2017) · JMIR Medical Informatics · doi:10.2196/medinform.7627 · Cited by 29

Models for financing the regulation of pharmaceutical promotion

Lexchin, J. (2012) · Globalization and Health · doi:10.1186/1744-8603-8-24 · Cited by 27

The rise and fall of machine learning methods in biomedical research

Koohy, H. (2017) · F1000Research · doi:10.12688/f1000research.13016.1 · Cited by 25

Data Mining for Biomedicine and Healthcare

Huang, Z., Juárez, J. M., & Li, X. (2017) · Journal of Healthcare Engineering · doi:10.1155/2017/7107629 · Cited by 24

Computer-Aided Clinical Trial Recruitment Based on Domain-Specific Language Translation: A Case Study of Retinopathy of Prematurity

Zhang, Y., Zhang, G., & Shang, Q. (2017) · Journal of Healthcare Engineering · doi:10.1155/2017/7862672 · Cited by 16

Adapting drug discovery to Artificial Intelligence

Okafo, G. N., Lakdawala, A. S., Sahni, V., Baldoni, J., Palovich, M. R., & Sikosek, T. (2018) · Cited by 15

Why 90% of clinical drug development fails and how to improve it?

Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763

Artificial intelligence in drug discovery and development

Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design

Vora, L. K., Gholap, A. D., Jetha, K. L., Singh, T. R. R., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,193

A Review of the Role of Artificial Intelligence in Healthcare

Al Kuwaiti, A., Nazer, K., Al-Reedy, A., Al-Shehri, S., Al-Muhanna, A., Subbarayalu, A. V., Al Muhanna, D., & Al-Muhanna, F. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060951 · Cited by 915

The Impact of Artificial Intelligence on Drug Discovery; A Comprehensive Review

Kazi, A. J., Gurav Mohini, A., Patil, S. R., Ritthe, P. V., Rudrurkar, M. N., Dharashive, V. M., & Shafi, D. S. (2024) · Asian Journal of Pharmaceutical Research and Development

A REVIEW ON "RECENT AI CONVERGENCE IN DRUG DEVELOPMENT AND SAURABH'S RECENT APPLICATION

Saurabh Hatzade1*, V. C. (2025) · World Journal of Pharmacy and Pharmaceutical Sciences · doi:10.5281/zenodo.17538832

Future prospective of AI in drug discovery

Bhowmick, M., Goswami, S., Bhowmick, P., Hait, S., Rath, D., & Yasmin, S. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.009 · Cited by 4

Accelerating Drug Discovery and Development: Harnessing AI for Enhanced Efficiency and Speed

Sajithabanu, S., Ramachandran, M. S., Anand, A. J., & Samundeeswari, K. (2026) · Springer eBooks · doi:10.1007/978-3-032-23626-5_13

The future of pharmaceuticals: Artificial intelligence in drug discovery and development

Fu, C., & Chen, Q. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101248 · Cited by 151